MicroRNAs/TP53 feedback circuitry in glioblastoma multiforme

被引:107
|
作者
Suh, Sung-Suk [1 ]
Yoo, Ji Young [2 ]
Nuovo, Gerard J. [1 ]
Jeon, Young-Jun [1 ]
Kim, Seokho [3 ]
Lee, Tae Jin [1 ]
Kim, Taewan [1 ]
Bakacs, Arianna [4 ]
Alder, Hansjuerg [1 ]
Kaur, Balveen [2 ]
Aqeilan, Rami I. [1 ,5 ]
Pichiorri, Flavia [6 ]
Croce, Carlo M. [1 ]
机构
[1] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Ctr Comprehens Canc, Columbus, OH 43210 USA
[2] Ohio State Univ, Dardinger Lab Neurooncol & Neurosci, Dept Neurol Surg, Comprehens Canc Ctr,Med Ctr, Columbus, OH 43220 USA
[3] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73104 USA
[4] Azienda Complesso Osped San Filippo Neri, Unita Operat Complessa Anat Patol, I-00135 Rome, Italy
[5] Hebrew Univ Jerusalem, Hadassah Med Sch, Lautenberg Ctr Gen & Tumor Immunol, Dept Immunol & Canc Res,Inst Med Res Israel Canad, IL-91120 Jerusalem, Israel
[6] Ohio State Univ, Coll Med, Dept Internal Med, Div Hematol, Columbus, OH 43210 USA
关键词
GROWTH-FACTOR RECEPTOR; CELL-CYCLE ARREST; C-MYC; PROMOTES APOPTOSIS; DOWN-REGULATION; P53; GENE; MDM2; INHIBITION; EXPRESSION; CANCER;
D O I
10.1073/pnas.1202465109
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
MicroRNAs (miRNAs) are increasingly implicated in regulating cancer initiation and progression. In this study, twomiRNAs, miR-25 and -32, are identified as p53-repressed miRNAs by p53-dependent negative regulation of their transcriptional regulators, E2F1 and MYC. However, miR-25 and -32 result in p53 accumulation by directly targeting Mdm2 and TSC1, which are negative regulators of p53 and the mTOR (mammalian target of rapamycin) pathway, respectively, leading to inhibition of cellular proliferation through cell cycle arrest. Thus, there is a recurrent autoregulatory circuit involving expression of p53, E2F1, and MYC to regulate the expression of miR-25 and -32, which are miRNAs that, in turn, control p53 accumulation. Significantly, overexpression of transfectedmiR-25 and -32 in glioblastoma multiforme cells inhibited growth of the glioblastoma multiforme cells in mouse brain in vivo. The results define miR-25 and -32 as positive regulators of p53, underscoring their role in tumorigenesis in glioblastoma.
引用
收藏
页码:5316 / 5321
页数:6
相关论文
共 50 条
  • [11] The TP53 website: an integrative resource centre for the TP53 mutation database and TP53 mutant analysis
    Leroy, Bernard
    Fournier, Jean Louis
    Ishioka, Chikashi
    Monti, Paola
    Inga, Alberto
    Fronza, Gilberto
    Soussi, Thierry
    NUCLEIC ACIDS RESEARCH, 2013, 41 (D1) : D962 - D969
  • [12] NEK2 promotes TP53 ubiquitination to enhance the proliferation and migration of TP53 wild-type glioblastoma cells
    Zhang, Yu
    Yu, Hao
    He, Mengyao
    Liu, Wenchao
    Xiao, Shengyou
    Wang, Xiangting
    Huang, Ping
    Huang, Qiang
    NEOPLASMA, 2024, 71 (03) : 255 - 265
  • [13] TP53, TP53 Target Genes (DRAM, TIGAR), and Autophagy
    Hu, Wanglai
    Chen, Song
    Thorne, Rick F.
    Wu, Mian
    AUTOPHAGY: BIOLOGY AND DISEASES: BASIC SCIENCE, 2019, 1206 : 127 - 149
  • [14] The role of TP53 gain-of-function mutation in multifocal glioblastoma
    Olafson, Lauren R.
    Gunawardena, Manuri
    Nixdorf, Sheri
    McDonald, Kerrie L.
    Rapkins, Robert W.
    JOURNAL OF NEURO-ONCOLOGY, 2020, 147 (01) : 37 - 47
  • [15] Molecular and genetic determinants of dysfunctional wild type TP53 in glioblastoma
    Zhao, Y.
    EUROPEAN JOURNAL OF CANCER, 2020, 138 : S27 - S28
  • [16] Gain of Function of Mutant TP53 in Glioblastoma: Prognosis and Response to Temozolomide
    Wang, Xiang
    Chen, Jin-xiu
    Liu, Jin-ping
    You, Chao
    Liu, Yan-hui
    Mao, Qing
    ANNALS OF SURGICAL ONCOLOGY, 2014, 21 (04) : 1337 - 1344
  • [17] Glioblastoma specimens with TP53 mutations do not show EGFRvIII amplification
    Ewelina, Stoczynska-Fidelus
    Monika, Witusik-Perkowska
    Mateusz, Banaszczyk
    Michal, Bienkowski
    Malgorzata, Szybka
    Sylwester, Piaskowski
    Magdalena, Cybula
    Dariusz, Jaskolski
    Wielistaw, Papierz
    Pawel, Liberski Piotr
    Piotr, Rieske
    CANCER GENETICS, 2011, 204 (05) : 282 - 283
  • [18] Analysis of the TP53 gene in laser-microdissected glioblastoma vasculature
    Kulla, A
    Burkhardt, K
    Meyer-Puttlitz, B
    Teesalu, T
    Asser, T
    Wiestler, OD
    Becker, AJ
    ACTA NEUROPATHOLOGICA, 2003, 105 (04) : 328 - 332
  • [19] Analysis of the TP53 gene in laser-microdissected glioblastoma vasculature
    Andres Kulla
    Karim Burkhardt
    Birgit Meyer-Puttlitz
    Tambet Teesalu
    Toomas Asser
    Otmar D. Wiestler
    Albert J. Becker
    Acta Neuropathologica, 2003, 105 : 328 - 332
  • [20] TP53 gain-of-function mutation promotes inflammation in glioblastoma
    Seok Won Ham
    Hee-Young Jeon
    Xiong Jin
    Eun-Jung Kim
    Jun-Kyum Kim
    Yong Jae Shin
    Yeri Lee
    Se Hoon Kim
    Seon Yong Lee
    Sunyoung Seo
    Min Gi Park
    Hye-Mi Kim
    Do-Hyun Nam
    Hyunggee Kim
    Cell Death & Differentiation, 2019, 26 : 409 - 425